TY - JOUR AU - Dohner, H. AU - Weisdorf, D. J. AU - Bloomfield, C. D. PY - 2015 DA - 2015// TI - Acute myeloid leukemia JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMra1406184 DO - 10.1056/NEJMra1406184 ID - Dohner2015 ER - TY - JOUR AU - Dohner, H. AU - Estey, E. H. AU - Amadori, S. AU - Appelbaum, F. R. AU - Buchner, T. AU - Burnett, A. K. PY - 2010 DA - 2010// TI - Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-07-235358 DO - 10.1182/blood-2009-07-235358 ID - Dohner2010 ER - TY - JOUR AU - Duval, M. AU - Klein, J. P. AU - He, W. AU - Cahn, J. Y. AU - Cairo, M. AU - Camitta, B. M. PY - 2010 DA - 2010// TI - Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.8852 DO - 10.1200/JCO.2010.28.8852 ID - Duval2010 ER - TY - JOUR AU - Gregory, T. K. AU - Wald, D. AU - Chen, Y. AU - Vermaat, J. M. AU - Xiong, Y. AU - Tse, W. PY - 2009 DA - 2009// TI - Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics JO - J Hematol Oncol. VL - 2 UR - https://doi.org/10.1186/1756-8722-2-23 DO - 10.1186/1756-8722-2-23 ID - Gregory2009 ER - TY - JOUR AU - Dohner, H. AU - Estey, E. AU - Grimwade, D. AU - Amadori, S. AU - Appelbaum, F. R. AU - Buchner, T. PY - 2017 DA - 2017// TI - Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel JO - Blood VL - 129 UR - https://doi.org/10.1182/blood-2016-08-733196 DO - 10.1182/blood-2016-08-733196 ID - Dohner2017 ER - TY - JOUR AU - Burnett, A. AU - Wetzler, M. AU - Lowenberg, B. PY - 2011 DA - 2011// TI - Therapeutic advances in acute myeloid leukemia JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.30.1820 DO - 10.1200/JCO.2010.30.1820 ID - Burnett2011 ER - TY - JOUR AU - Tallman, M. S. AU - Gilliland, D. G. AU - Rowe, J. M. PY - 2005 DA - 2005// TI - Drug therapy for acute myeloid leukemia JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-01-0178 DO - 10.1182/blood-2005-01-0178 ID - Tallman2005 ER - TY - JOUR AU - Gangaraju, V. K. AU - Lin, H. PY - 2009 DA - 2009// TI - MicroRNAs: key regulators of stem cells JO - Nat Rev Mol Cell Biol VL - 10 UR - https://doi.org/10.1038/nrm2621 DO - 10.1038/nrm2621 ID - Gangaraju2009 ER - TY - JOUR AU - Schwind, S. AU - Maharry, K. AU - Radmacher, M. D. AU - Mrozek, K. AU - Holland, K. B. AU - Margeson, D. PY - 2010 DA - 2010// TI - Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.29.2953 DO - 10.1200/JCO.2010.29.2953 ID - Schwind2010 ER - TY - JOUR AU - Sun, S. M. AU - Rockova, V. AU - Bullinger, L. AU - Dijkstra, M. K. AU - Dohner, H. AU - Lowenberg, B. PY - 2013 DA - 2013// TI - The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2012.158 DO - 10.1038/leu.2012.158 ID - Sun2013 ER - TY - JOUR AU - Eisfeld, A. K. AU - Marcucci, G. AU - Maharry, K. AU - Schwind, S. AU - Radmacher, M. D. AU - Nicolet, D. PY - 2012 DA - 2012// TI - miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-02-408492 DO - 10.1182/blood-2012-02-408492 ID - Eisfeld2012 ER - TY - JOUR AU - Middeke, J. M. AU - Herold, S. AU - Rucker-Braun, E. AU - Berdel, W. E. AU - Stelljes, M. AU - Kaufmann, M. PY - 2016 DA - 2016// TI - TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation JO - Br J Haematol VL - 172 UR - https://doi.org/10.1111/bjh.13912 DO - 10.1111/bjh.13912 ID - Middeke2016 ER - TY - JOUR AU - Lai, D. AU - Visser-Grieve, S. AU - Yang, X. PY - 2012 DA - 2012// TI - Tumour suppressor genes in chemotherapeutic drug response JO - Biosci Rep VL - 32 UR - https://doi.org/10.1042/BSR20110125 DO - 10.1042/BSR20110125 ID - Lai2012 ER - TY - JOUR AU - El-Deiry, W. S. PY - 2003 DA - 2003// TI - The role of p53 in chemosensitivity and radiosensitivity JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206949 DO - 10.1038/sj.onc.1206949 ID - El-Deiry2003 ER - TY - JOUR AU - Liu, P. AU - Hu, Y. AU - Ma, L. AU - Du, M. AU - Xia, L. AU - Hu, Z. PY - 2015 DA - 2015// TI - miR-425 inhibits melanoma metastasis through repression of PI3 K-Akt pathway by targeting IGF-1 JO - Biomed Pharmacother VL - 75 UR - https://doi.org/10.1016/j.biopha.2015.08.010 DO - 10.1016/j.biopha.2015.08.010 ID - Liu2015 ER - TY - JOUR AU - Ma, J. AU - Liu, J. AU - Wang, Z. AU - Gu, X. AU - Fan, Y. AU - Zhang, W. PY - 2014 DA - 2014// TI - NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1beta induction JO - Mol Cancer. VL - 13 UR - https://doi.org/10.1186/1476-4598-13-40 DO - 10.1186/1476-4598-13-40 ID - Ma2014 ER - TY - JOUR AU - Yan, Y. F. AU - Gong, F. M. AU - Wang, B. S. AU - Zheng, W. PY - 2017 DA - 2017// TI - MiR-425-5p promotes tumor progression via modulation of CYLD in gastric cancer JO - Eur Rev Med Pharmacol Sci. VL - 21 ID - Yan2017 ER - TY - JOUR AU - Leva, G. AU - Piovan, C. AU - Gasparini, P. AU - Ngankeu, A. AU - Taccioli, C. AU - Briskin, D. PY - 2013 DA - 2013// TI - Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status JO - PLoS Genet VL - 9 UR - https://doi.org/10.1371/journal.pgen.1003311 DO - 10.1371/journal.pgen.1003311 ID - Leva2013 ER - TY - JOUR AU - Liu, L. AU - Zhao, Z. AU - Zhou, W. AU - Fan, X. AU - Zhan, Q. AU - Song, Y. PY - 2015 DA - 2015// TI - Enhanced expression of miR-425 promotes esophageal squamous cell carcinoma tumorigenesis by targeting SMAD2 JO - J Genet Genomics. VL - 42 UR - https://doi.org/10.1016/j.jgg.2015.09.010 DO - 10.1016/j.jgg.2015.09.010 ID - Liu2015 ER - TY - JOUR AU - Abdel-Wahab, O. AU - Levine, R. L. PY - 2010 DA - 2010// TI - Metabolism and the leukemic stem cell JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20100523 DO - 10.1084/jem.20100523 ID - Abdel-Wahab2010 ER - TY - JOUR AU - Jaiswal, S. AU - Jamieson, C. H. AU - Pang, W. W. AU - Park, C. Y. AU - Chao, M. P. AU - Majeti, R. PY - 2009 DA - 2009// TI - CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis JO - Cell VL - 138 UR - https://doi.org/10.1016/j.cell.2009.05.046 DO - 10.1016/j.cell.2009.05.046 ID - Jaiswal2009 ER - TY - JOUR AU - Fu, W. AU - Li, J. AU - Zhang, W. AU - Li, P. PY - 2017 DA - 2017// TI - High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma JO - Biomed Pharmacother VL - 93 UR - https://doi.org/10.1016/j.biopha.2017.06.030 DO - 10.1016/j.biopha.2017.06.030 ID - Fu2017 ER - TY - JOUR AU - Kong, F. AU - Gao, F. AU - Li, H. AU - Liu, H. AU - Zhang, Y. AU - Zheng, R. PY - 2016 DA - 2016// TI - CD47: a potential immunotherapy target for eliminating cancer cells JO - Clin Transl Oncol VL - 18 UR - https://doi.org/10.1007/s12094-016-1489-x DO - 10.1007/s12094-016-1489-x ID - Kong2016 ER - TY - JOUR AU - Meng, Z. AU - Moroishi, T. AU - Mottier-Pavie, V. AU - Plouffe, S. W. AU - Hansen, C. G. AU - Hong, A. W. PY - 2015 DA - 2015// TI - MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway JO - Nat Commun. VL - 6 UR - https://doi.org/10.1038/ncomms9357 DO - 10.1038/ncomms9357 ID - Meng2015 ER - TY - JOUR AU - Kim, J. AU - Guan, K. L. PY - 2011 DA - 2011// TI - Amino acid signaling in TOR activation JO - Annu Rev Biochem VL - 80 UR - https://doi.org/10.1146/annurev-biochem-062209-094414 DO - 10.1146/annurev-biochem-062209-094414 ID - Kim2011 ER - TY - JOUR AU - Mundi, P. S. AU - Sachdev, J. AU - McCourt, C. AU - Kalinsky, K. PY - 2016 DA - 2016// TI - AKT in cancer: new molecular insights and advances in drug development JO - Br J Clin Pharmacol VL - 82 UR - https://doi.org/10.1111/bcp.13021 DO - 10.1111/bcp.13021 ID - Mundi2016 ER - TY - JOUR AU - Hsu, C. L. AU - Lee, E. X. AU - Gordon, K. L. AU - Paz, E. A. AU - Shen, W. C. AU - Ohnishi, K. PY - 2018 DA - 2018// TI - MAP4K3 mediates amino acid-dependent regulation of autophagy via phosphorylation of TFEB JO - Nat Commun. VL - 9 UR - https://doi.org/10.1038/s41467-018-03340-7 DO - 10.1038/s41467-018-03340-7 ID - Hsu2018 ER - TY - JOUR AU - Xiong, Y. AU - Li, Z. AU - Ji, M. AU - Tan, A. C. AU - Bemis, J. AU - Tse, J. V. PY - 2011 DA - 2011// TI - MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML JO - Br J Haematol VL - 153 UR - https://doi.org/10.1111/j.1365-2141.2011.08662.x DO - 10.1111/j.1365-2141.2011.08662.x ID - Xiong2011 ER - TY - JOUR AU - Heldin, C. H. AU - Miyazono, K. AU - Dijke, P. PY - 1997 DA - 1997// TI - TGF-beta signalling from cell membrane to nucleus through SMAD proteins JO - Nature VL - 390 UR - https://doi.org/10.1038/37284 DO - 10.1038/37284 ID - Heldin1997 ER - TY - JOUR AU - Benito, J. AU - Shi, Y. AU - Szymanska, B. AU - Carol, H. AU - Boehm, I. AU - Lu, H. PY - 2011 DA - 2011// TI - Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104 JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0023108 DO - 10.1371/journal.pone.0023108 ID - Benito2011 ER - TY - JOUR AU - Zhang, H. AU - Akman, H. O. AU - Smith, E. L. AU - Zhao, J. AU - Murphy-Ullrich, J. E. AU - Batuman, O. A. PY - 2003 DA - 2003// TI - Cellular response to hypoxia involves signaling via Smad proteins JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-02-0629 DO - 10.1182/blood-2002-02-0629 ID - Zhang2003 ER - TY - JOUR AU - Azizidoost, S. AU - Vijay, V. AU - Cogle, C. R. AU - Khodadi, E. AU - Saki, N. PY - 2017 DA - 2017// TI - The role and clinical implications of the endosteal niche and osteoblasts in regulating leukemia JO - Clin Transl Oncol VL - 19 UR - https://doi.org/10.1007/s12094-017-1642-1 DO - 10.1007/s12094-017-1642-1 ID - Azizidoost2017 ER - TY - JOUR AU - Zhang, Q. AU - Zhang, Q. AU - Li, Q. AU - Liu, B. AU - Wang, Y. AU - Lin, D. PY - 2015 DA - 2015// TI - Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance JO - Int J Lab Hematol. VL - 37 UR - https://doi.org/10.1111/ijlh.12309 DO - 10.1111/ijlh.12309 ID - Zhang2015 ER - TY - JOUR AU - Kharas, M. G. AU - Yusuf, I. AU - Scarfone, V. M. AU - Yang, V. W. AU - Segre, J. A. AU - Huettner, C. S. PY - 2007 DA - 2007// TI - KLF4 suppresses transformation of pre-B cells by ABL oncogenes JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-03-011106 DO - 10.1182/blood-2006-03-011106 ID - Kharas2007 ER - TY - JOUR AU - Morris, V. A. AU - Cummings, C. L. AU - Korb, B. AU - Boaglio, S. AU - Oehler, V. G. PY - 2016 DA - 2016// TI - Deregulated KLF4 expression in myeloid leukemias alters cell proliferation and differentiation through MicroRNA and gene targets JO - Mol Cell Biol VL - 36 UR - https://doi.org/10.1128/MCB.00712-15 DO - 10.1128/MCB.00712-15 ID - Morris2016 ER -